GlassScriptPhysician profile
Barry Curtis
NPI 1750795639
$7,913.85
in general payments reported to CMS, 2019-2025
20 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,055 · 2020: $501 · 2021: $360 · 2022: $1,283 · 2023: $686 · 2024: $1,161 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,714.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,886.08 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb Americas INC. | $1,322.01 | 2022-2025 | Infuse, Miebo, Xiidra |
| Biotissue Holdings INC. | $1,174.82 | 2019-2025 | |
| Coopervision INC. | $976.22 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $544.04 | 2020-2025 | Cequa |
| Genzyme Corporation | $314.76 | 2019-2022 | |
| Oyster Point Pharma, INC. | $251.82 | 2022-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $209.91 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $173.29 | 2024-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $164.94 | 2019-2023 | |
| Astellas Pharma US INC | $141.11 | 2025 | Izervay |
| Maculogix, INC. | $140.65 | 2019 | |
| Allergan, INC. | $131.52 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $121.82 | 2024 | Xdemvy |
| Optos, INC. | $116.88 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $102.72 | 2023 | |
| Harrow Eye, LLC | $78.19 | 2025 | Vevye |
| Abb Con-Cise Optical Group LLC | $29.63 | 2019 | |
| Kala Pharmaceuticals, INC. | $17.76 | 2021 | |
| Thea Pharma INC. | $15.68 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.